Stocks · News reference

Morgan Stanley Maintains Overweight on Cencora, Raises Price Target to $346

Aug 7, 2026, 6:57 PMBenzinga Newsdesk

Morgan Stanley analyst Erin Wright maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $342 to $346.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 19, 2026, 1:46 PMBenzinga Newsdesk
RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330
RBC Capital analyst Ryan Halsted initiates coverage on Cencora (NYSE:COR) with a Sector Perform rating and announces Price Target of $330.
Read original at benzinga
COR
SEC EDGARAug 14, 2026, 8:06 PMSEC EDGAR
8-K filing — Cencora, Inc. (COR)
Filed: 2026-08-14 AccNo: 0001104659-26-097096 Size: 240 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgar
COR
BenzingaAug 12, 2026, 5:24 PMBenzinga Newsdesk
Cencora shares are trading lower after the company announced that certain Walgreens volume moved outside its business beginning July 1, 2026.
Read original at benzinga
COR
BenzingaAug 12, 2026, 4:46 PMBenzinga Newsdesk
Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged
Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "Company" or "Cencora") separate from the prime vendor agreement began moving outside the Company. The prime
Read original at benzinga
COR